Hormonal Causes of Male Sexual Dysfunctions and Their Management (Hyperprolactinemia, Thyroid Disorders, GH Disorders, and DHEA)

Published on Mar 1, 2013in The Journal of Sexual Medicine3.293
· DOI :10.1111/J.1743-6109.2012.02735.X
Mario Maggi160
Estimated H-index: 160
(UniFI: University of Florence),
Jaques Buvat5
Estimated H-index: 5
+ 2 AuthorsLuiz Otavio Torres16
Estimated H-index: 16
Sources
Abstract
ABSTRACT Introduction Besides hypogonadism, other endocrine disorders have been associated with male sexual dysfunction (MSD). Aim To review the role of the pituitary hormone prolactin (PRL), growth hormone (GH), thyroid hormones, and adrenal androgens in MSD. Methods A systematic search of published evidence was performed using Medline (1969 to September 2011). Oxford Centre for Evidence‐Based Medicine—Levels of Evidence (March 2009) was applied when possible. Main Outcome Measures The most important evidence regarding the role played by PRL, GH, thyroid, and adrenal hormone was reviewed and discussed. Results Only severe hyperprolactinemia (>35 ng/mL or 735 mU/L), often related to a pituitary tumor, has a negative impact on sexual function, impairing sexual desire, testosterone production, and, through the latter, erectile function due to a dual effect: mass effect and PRL‐induced suppression on gonadotropin secretion. The latter is PRL‐level dependent. Emerging evidence indicates that hyperthyroidism is associated with an increased risk of premature ejaculation and might also be associated with erectile dysfunction (ED), whereas hypothyroidism mainly affects sexual desire and impairs the ejaculatory reflex. However, the real incidence of thyroid dysfunction in subjects with sexual problems needs to be evaluated. Prevalence of ED and decreased libido increase in acromegalic patients; however, it is still a matter of debate whether GH excess (acromegaly) may create effects due to a direct overproduction of GH/insulin‐like growth factor 1 or because of the pituitary mass effects on gonadotropic cells, resulting in hypogonadism. Finally, although dehydroepiandrosterone (DHEA) and its sulfate have been implicated in a broad range of biological derangements, controlled trials have shown that DHEA administration is not useful for improving male sexual function. Conclusions While the association between hyperprolactinemia and hypoactive sexual desire is well defined, more studies are needed to completely understand the role of other hormones in regulating male sexual functioning. Maggi M, Buvat J, Corona G, Guay A, and Torres LO. Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA). J Sex Med 2013;10:661–677.
📖 Papers frequently viewed together
1,242 Citations
104 Citations
114 Citations
References107
Newest
#1Abdulmaged M. Traish (BU: Boston University)H-Index: 75
#2H. Paco Kang (BU: Boston University)H-Index: 1
Last. André T. Guay (Tufts University)H-Index: 53
view all 4 authors...
ABSTRACT Introduction The circulation of large amounts of dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEA‐S) suggests a physiological role in human physiology. In the central nervous system, DHEA is considered a neurosteroid with a wide range of functions. Aim The goal of this review is to discuss metabolism, biochemical, and physiological mechanism of DHEA action and the potential role of DHEA in aging and in ameliorating a host of pathological conditions, associated with aging....
152 CitationsSource
#1Giovanni Corona (UniFI: University of Florence)H-Index: 84
#2Giulia RastrelliH-Index: 48
Last. Mario Maggi (UniFI: University of Florence)H-Index: 160
view all 9 authors...
Objective: To verify whether hypogonadism represents a risk factor for cardiovascular (CV) morbidity and mortality and to verify whether testosterone replacement therapy (TRT) improves CV parameters in subjects with known CV diseases (CVDs). Design: Meta-analysis. Methods: An extensive Medline search was performed using the following words ‘testosterone, CVD, and males’. The search was restricted to data from January 1, 1969, up to January 1, 2011. Results: Of the 1178 retrieved articles, 70 wer...
282 CitationsSource
#1Alexander W. Pastuszak (BCM: Baylor College of Medicine)H-Index: 24
#2J S Liu (BCM: Baylor College of Medicine)H-Index: 1
Last. Mohit Khera (BCM: Baylor College of Medicine)H-Index: 31
view all 7 authors...
IGF-1 levels are significantly correlated with patient-reported measures of sexual function
2 CitationsSource
#1Fred R. Sattler (SC: University of Southern California)H-Index: 51
#2Shalender Bhasin (BU: Boston University)H-Index: 110
Last. Stanley P. Azen (SC: University of Southern California)H-Index: 102
view all 14 authors...
Summary Objectives To determine the durability of anabolic effects and adverse events (AEs) after stopping testosterone and growth hormone supplementation in older men. Design Secondary analysis of a double-masked, randomized controlled trial of testosterone gel (5 or 10 g/daily) plus rhGH (0, 3 or 5 μg/kg/day) with follow-up of outcomes 3 months later. Participants A total of 108 community-dwelling 65- to 90-year-old men. Measurements Testosterone and IGF-1 levels, body composition (DEXA), 1-re...
10 CitationsSource
Recombinant GH therapy is normally administered to GH-deficient children in order to achieve a satisfactory height — the main target during childhood and adolescence. However, the role of GH does not end once final height has been reached, but continues during the so-called transition period. In this phase of life, the body undergoes several changes, both physical and psychological, that culminate in adulthood. During this period, GH has a part in numerous metabolic functions. These include the ...
8 CitationsSource
#1Giovanni Corona (UniFI: University of Florence)H-Index: 84
#2Giulia Rastrelli (UniFI: University of Florence)H-Index: 48
Last. Mario Maggi (UniFI: University of Florence)H-Index: 160
view all 10 authors...
Summary The physiological role of prolactin (PRL) in men is not completely clarified. We previously reported that in subjects consulting for sexual dysfunction, lower PRL plasma levels were associated with worse lipid and glycaemic profile, as well as with a higher prevalence of metabolic syndrome and arteriogenic erectile dysfunction (ED). The aim of this study was to assess possible associations between PRL levels and incident major cardiovascular events (MACE) in subjects with ED. When only s...
42 CitationsSource
A 37-year-old woman receives a diagnosis of Graves' disease and is treated with methimazole for 1 year. After completing this treatment, she presents with recurrent symptoms of hyperthyroidism. Radioiodine ablation is recommended.
109 CitationsSource
#2Kris PoppeH-Index: 28
Last. Daniel GlinoerH-Index: 56
view all 3 authors...
Via its interaction in several pathways, normal thyroid function is important to maintain normal reproduction. In both genders, changes in SHBG and sex steroids are a consistent feature associated with hyper- and hypothyroidism and were already reported many years ago. Male reproduction is adversely affected by both thyrotoxicosis and hypothyroidism. Erectile abnormalities have been reported. Thyrotoxicosis induces abnormalities in sperm motility, whereas hypothyroidism is associated with abnorm...
820 CitationsSource
Context: Macroprolactinemia is a common finding in patients with hyperprolactinemia. There are no published long-term follow-up studies. Objective: The aim of this study was to describe findings after prolonged follow-up in a previously published cohort of patients with macroprolactinemia. Study Population: We studied 51 patients identified as having macroprolactinemia after polyethylene glycol precipitation. Design: Clinical assessment and serum prolactin assay were repeated in 51 patients with...
31 CitationsSource
Methimazole (MMI) and propylthiouracil (PTU) are the main antithyroid drugs used for hyperthyroidism. They inhibit the synthesis of thyroid hormone at various levels and are used as the primary treatment for hyperthyroidism or as a preparation before radioiodine therapy or thyroidectomy. MMI is the drug of choice because of its widespread availability, longer half-life and small number of severe side effects. Drugs of second choice are potassium perchlorate, beta blockers, iodine, lithium carbon...
34 CitationsSource
Cited By87
Newest
#1Andrea Salonia (UniSR: Vita-Salute San Raffaele University)H-Index: 82
#2C. Bettocchi (University of Foggia)H-Index: 1
Last. Murat Gul (Selçuk University)H-Index: 8
view all 0 authors...
Abstract null null Context null The present summary of the European Association of Urology (EAU) guidelines is based on the latest guidelines on male sexual health published in March 2021, with a last comprehensive update in January 2021. null null null Objective null To present a summary of the 2021 version of the EAU guidelines on sexual and reproductive health. null null null Evidence acquisition null A literature review was performed up to January 2021. The guidelines were updated, and a str...
2 CitationsSource
Several hormones contribute to ensure penile erection, a neurovascular phenomenon in which nitric oxide plays a major role. Erectile dysfunction (ED), which is defined as the persistent inability to obtain or maintain penile erection sufficient for a satisfactory sexual performance, may be due to arteriogenic, neurogenic, iatrogenic, but also endocrinological causes. The hypothalamus–pituitary axis plays a central role in the endocrine system and represents a fundamental link between the brain a...
Source
#1Maolei Shen (Taizhou University)H-Index: 2
#2Xin Li (Taizhou University)H-Index: 2
Last. Shankun Zhao (Taizhou University)H-Index: 9
view all 9 authors...
INTRODUCTION Many investigators have found a detrimental effect on sexual functioning developed by hypothyroidism in both sexes, but a cumulative analysis has not been conducted. AIM This study aims to summarize and quantify the association between overt or subclinical hypothyroidism and the risk of sexual dysfunction (SD) through a meta-analysis. METHODS 4 electronic databases were systematically searched. The quality of evidence was rated by the GRADE approach. This meta-analysis was registere...
Source
#1Zhengyuan Chen (Fudan University)H-Index: 4
#2Xiaoqing Shao (Fudan University)H-Index: 7
Last. Zhaoyun Zhang (Fudan University Shanghai Medical College)H-Index: 1
view all 18 authors...
Objective: To determine the risk factors for erectile dysfunction (ED) in male patients with acromegaly and to prospectively investigate the short-term changes of erectile function after surgery or medical treatment. Methods. Sixty-three male patients were subjected to nocturnal penile tumescence and rigidity (NPTR) test for the evaluation of erectile function. The measurement of serum nitric oxide (NO) was also performed. Twenty-seven patients were re-evaluated by NPTR after surgery or long-ter...
Source
#1Ahmed M Bakr (Suez Canal University)
#2Amro A El-Sakka (Suez Canal University)
Last. Ahmed I. El-Sakka (Suez Canal University)H-Index: 26
view all 3 authors...
Introduction: The effectiveness of phosphodiesterase type 5 inhibitors (PDE5i) in treating erectile dysfunction (ED) creates a new field of both medical practice and pharmaceutical manufacturing. B...
Source
#1Jun Hamahara (Okayama University)H-Index: 1
#2Hiroyuki Honda (Okayama University)H-Index: 1
Last. Fumio Otsuka (Okayama University)H-Index: 35
view all 10 authors...
To determine the clinical characteristics of low androgen status in adult males with diabetes, we retrospectively analyzed the medical records of patients with type 2 diabetes mellitus in whom serum free testosterone (FT) levels were examined for 1 year. Among the 46 patients (56 ± 1.5 years old), decreases in serum FT levels to < 8.5 pg/ml (indicating the occurrence of late-onset hypogonadism [LOH]) were detected in 18 (39%). The per-centages of patients with low FT levels were high in the ≥ 50...
Source
#1Maria Laura Monzani (University of Modena and Reggio Emilia)H-Index: 4
#2Simone Pederzoli (University of Modena and Reggio Emilia)H-Index: 3
Last. Vincenzo Rochira (University of Modena and Reggio Emilia)H-Index: 34
view all 6 authors...
Context Although sexuality influences well-being and quality of life (QoL), studies on sexual dysfunction (SD) in adult growth hormone deficiency (AGHD) patients are lacking. Objective To investigate the prevalence of SD in AGHD patients grouped according to recombinant human growth hormone (r-hGH) therapy. Design Prospective, cross-over, 24 months, monocentric study. Setting Real-life clinical setting in a tertiary, endocrinological center. Patients 83 AGHD patients (31 women, 52 men, mean age ...
Source
Male sexual dysfunction has many different causes and is often multifactorial in nature. We aim to review the effects that testosterone (T), estrogen, thyroid hormone, prolactin (PRL), and cortisol have on male sexual function. T deficiency can cause decreased libido and diminished erectile function. Estrogen is necessary for sexual drive but is postulated to inhibit erectile function when elevated. Hyperthyroidism is associated with premature ejaculation (PE), hypothyroidism is associated with ...
Source
#1Francesco Lotti (UniFI: University of Florence)H-Index: 37
#2F. Frizza (UniFI: University of Florence)H-Index: 2
Last. Mario Maggi (UniFI: University of Florence)H-Index: 160
view all 31 authors...
BACKGROUND: Infertility affects 7-12% of men and its etiology is unknown in half of cases. To fill this gap, use of the male genital tract colour-Doppler ultrasound (MGT-CDUS) has progressively expanded. However, MGT-CDUS still suffers from lack of standardization. Hence, the European Academy of Andrology(EAA) has promoted a multicenter study ("EAA ultrasound study") to assess MGT-CDUS characteristics of healthy-fertile men to obtain normative parameters. OBJECTIVES: To report (a)the development...
4 CitationsSource
#1Yin Pan (Taizhou University)H-Index: 1
#2Qiang Xie (Southern Medical University)H-Index: 3
Last. Shankun Zhao (Taizhou University)H-Index: 9
view all 9 authors...
Abstract Background Numerous studies have shown the detrimental effects of overt hyperthyroidism on sexual functioning but a quantitative result has not yet been synthesized. Aim To conduct a systematic review and meta-analysis that quantifies the association between overt hyperthyroidism and the risk of sexual dysfunction (SD). Methods A meta-analysis of studies in the literature published prior to February 1, 2020, from 4 electronic databases (MEDLINE, Embase, Cochrane Library databases, and P...
Source